Literature DB >> 18433990

Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells.

Zhiyong Zhang1, Lili Cao, Jie Li, Xiaohong Liang, Yugang Liu, Hua Liu, Juan Du, Zhonghua Qu, Min Cui, Suxia Liu, Lifen Gao, Chunhong Ma, Lining Zhang, Lihui Han, Wensheng Sun.   

Abstract

Resistance to anoikis is a hallmark of human malignancies. Our results showed that hepatoma cells resisted anoikis by non-proliferation, non-apoptosis and cell cycle arrest which were termed synoikis-like. These synoikis-like cells are more resistant to extracellular stimuli and could spontaneously attach and proliferate again under suitable conditions, which indicate a reversible property of these cells. Microarray expression profile reveals the change of molecules involved in the synoikis-like hepatoma cells and our data indicated that ANGPTL4 contributed to anoikis resistance of hepatoma cells. These results demonstrated that hepatoma cells might resist anoikis through a synoikis-like survival style, which may facilitate tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433990     DOI: 10.1016/j.canlet.2008.03.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.

Authors:  Yuen-Keng Ng; Elaine Yue Ling Wong; Cecilia Pik Yuk Lau; Jessica Pui Lan Chan; Sze Chuen Cesar Wong; Andrew Sai-Kit Chan; Maggie Pui Chun Kwan; Sai-Wah Tsao; Chi-Man Tsang; Paul Bo San Lai; Anthony Tak Cheung Chan; Vivian Wai Yan Lui
Journal:  Invest New Drugs       Date:  2010-08-07       Impact factor: 3.850

2.  A transfection method of PS-asODNs targeting ANGPTL4 in multicellular structures of hepatocarcinoma cell line.

Authors:  Q Kong; G Wu; L Han; Z Zhang; J Du; W Sun; L Cao
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

3.  Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis.

Authors:  Kirk Jensen; Aneeta Patel; Joanna Klubo-Gwiezdzinska; Andrew Bauer; Vasyl Vasko
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

4.  Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.

Authors:  Qing Wei; Pengbo Guo; Kun Mu; Ying Zhang; Wei Zhao; Wanwan Huai; Yumin Qiu; Tao Li; Xiaomin Ma; Yafei Liu; Xiaoyan Chen; Lihui Han
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

5.  Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.

Authors:  Hao Liu; Wei Chen; Xiao Zhi; En-Jiang Chen; Tao Wei; Jian Zhang; Jian Shen; Li-Qiang Hu; Bin Zhao; Xin-Hua Feng; Xue-Li Bai; Ting-Bo Liang
Journal:  Oncogene       Date:  2018-05-22       Impact factor: 9.867

6.  Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells.

Authors:  Pithi Chanvorachote; Varisa Pongrakhananon; Hasseri Halim
Journal:  Mol Cell Biochem       Date:  2014-10-29       Impact factor: 3.396

7.  Up-regulation of Tropomyosin related kinase B contributes to resistance to detachment-induced apoptosis in hepatoma multicellular aggregations.

Authors:  Zhiyong Zhang; Lihui Han; Yugang Liu; Xiaohong Liang; Wensheng Sun
Journal:  Mol Biol Rep       Date:  2008-07-02       Impact factor: 2.316

8.  High dose of extracellular ATP switched autophagy to apoptosis in anchorage-dependent and anchorage-independent hepatoma cells.

Authors:  Qing Wei; Ying Zhang; Lei Sun; Xiaoqing Jia; Wanwan Huai; Chengcheng Yu; Zhengkun Wan; Lihui Han
Journal:  Purinergic Signal       Date:  2013-06-19       Impact factor: 3.765

9.  Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.

Authors:  Y Okugawa; K Tanaka; Y Inoue; M Kawamura; A Kawamoto; J Hiro; S Saigusa; Y Toiyama; M Ohi; K Uchida; Y Mohri; M Kusunoki
Journal:  Br J Cancer       Date:  2012-11-22       Impact factor: 7.640

10.  Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.

Authors:  T Adhikary; D T Brandt; K Kaddatz; J Stockert; S Naruhn; W Meissner; F Finkernagel; J Obert; S Lieber; M Scharfe; M Jarek; P M Toth; F Scheer; W E Diederich; S Reinartz; R Grosse; S Müller-Brüsselbach; R Müller
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.